Dihydrojasmone

CAS No. 1128-08-1

Dihydrojasmone( —— )

Catalog No. M21347 CAS No. 1128-08-1

Dihydrojasmone is a natural product from bergamot.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Dihydrojasmone
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrojasmone is a natural product from bergamot.
  • Description
    Dihydrojasmone is a natural product from bergamot.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1128-08-1
  • Formula Weight
    166.26
  • Molecular Formula
    C11H18O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (601.47 mM)
  • SMILES
    CCCCCC1=C(C)CCC1=O
  • Chemical Name
    3-methyl-2-pentylcyclopent-2-en-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nakashita Y Hesse M . Conversion of Nitroheptane to Dihydrojasmone[J]. Planta Medica 1985 51(04):349-350.
molnova catalog
related products
  • Amylin, amide, human

    Amylin, a 37-amino acid polypeptide that is structurally related to calcitonin, is secreted from the B cells of the pancreas. Amylin has anoretic effects in rats. Amylin may be responsible for the etiology of insulin resistance of type II diabetes mellitus through its modulation of peripheral effects of insulin.

  • JNJ-65355394

    JNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe.

  • 3-Epiursolic acid

    3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.